-
- PARIS JEAN-MARC
- Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville
-
- FRANCOIS JEAN
- Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville
-
- MOLHERAT CHRISTIAN
- Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville
-
- ALBANO FRANCA
- Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville
-
- ROBIN MIREILLE
- Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville
-
- VUILHORGNE MARC
- Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville
-
- BARRIERE JEAN-CLAUDE
- Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville
この論文をさがす
説明
Pristinamycin IA was modified in a two-step procedure to give original derivatives possessing a tricyclic nucleus (8a, 8b, 8c) or a substituted pyrrole ring (10a, 10b) in place of the natural exocyclic 3-hydroxy-picolinoyl residue. This transformation involved firstly preparation of pyridinium betaines 5 from pristinamycin IA and secondly a 1-3 dipolar cycloaddition between 5 and N-substituted maleimides or diethyl ace tylenedicar boxy late. The compounds obtained were evaluated as antibacterial agents alone and in association with pristinamycin IIA.
収録刊行物
-
- The Journal of Antibiotics
-
The Journal of Antibiotics 48 (7), 676-682, 1995
公益財団法人 日本感染症医薬品協会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204149136000
-
- NII論文ID
- 10004794220
-
- NII書誌ID
- AA0069330X
-
- ISSN
- 18811469
- 00218820
-
- PubMed
- 7649868
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可